The pharmacological potencies of the resins from three different samples of Brazilian marihuana (A, B and C) were determined through corneal areflexia in rabbits, decrease of spontaneous motor activity and induction of catatonia in mice, and decrease of rope climbing performance of rats. 2 The A9 -tetrahydrocannabinol (A9 THC) content of the marihuanas, measured by gas chromatography, was 0.82, 2.02 and 0.52%, respectively, for samples A, B and C. Approximately 2% cannabinol was present in samples A and B whereas the content of cannabidiol was approximately 0.1%. 3 The petroleum ether extraction of the samples A, B and C yielded, respectively, 12.06, 14.56 and 4.26% of resin. 4 In all animal tests resin B was nearly twice as active as resin A, whereas C was the weakest. 5 The smoke of the marihuana samples was inhaled by 33 human subjects, under a double-blind standardized procedure. Pulse rate, a time production task and an evaluation of psychological effects were recorded. 6 The smoke of 250 mg of sample B provoked disruption of the time production task, increased pulse rate, and induced strong psychological reactions in four of the six subjects who received it. Similar effects, although slightly smaller, were obtained with 500 mg of sample A. On the other hand, 500 mg of sample C did not differ from placebo. 7 It is suggested that it is possible by means of animal tests to predict the potency of a marihuana sample in man. 8 In parallel experiments, A9-THC was administered to other human subjects and to laboratory animals in a manner similar to that in which the marihuana samples were administered. 9 Comparison of the results between the marihuanas and A9 -THC showed that in man and in the laboratory animals marihuanas A and B induced effects two to four times greater than expected from their A9 -THC content.
Introduction
The first report dealing with the administration of marihuana to humans in a double-blind procedure did not appear until 1968 (Weil, Zinberg & Nelsen, 1968) . These authors and Manno, Kiplinger, Haine, Bennett & Forney (1970) have pointed out that the way the subjects smoke a marihuana cigarette, has often not been taken into consideration, and yet this may be important in determining the amount of active principles delivered to a subject. Furthermore, in many of the studies the content of (-)-A9 -trans-tetrahydrocannabinol (A9 -THC) in the plant material used was either not mentioned or reported imprecisely (Crancer, Diller, Delay, Wallace & Haykin, 1969; Caldwell, Myers, Domino & Merrian, 1969a & b; Kiplinger & Scholz, 1971) . The chemical composition of marihuana may be another important factor. It is not yet certain whether the potencies of different marihuana samples are due only to their content of A9 -THC or to differences in their chemical compositions. It has been suggested that other cannabinoid compounds may interfere with the action of A9 -THC (Carlini, Santos, Claussen, Bieniek & Korte, 1970; Isbell, 1971; Kubena & Barry, 1972) . On the other hand, as far as we know, no previous report has been published in which a marihuana sample smoked by human beings had been previously studied in laboratory animals in order to assess its pharmacological potency. It has been suggested that certain tests in laboratory animals can detect differences in potency between samples of marihuana which correlate with their content of A9 -THC (Carlini et al., 1970) .
Recently, Renault, Schuster, Heinrich & Freedman (1971) developed a simple method of administering marihuana smoke to humans which allows for the standardization of smoke administration. Briefly, the method consists of burning a known amount of marihuana in a pipe connected to a spirometer. The subject then inhales the smoke from the spirometer under standardized conditions. In the present experiments three different samples of marihuana and A9 -THC were given to human beings and to laboratory animals in order to observe: a) whether the potencies of the samples were the same among the species studied; and b) whether the effects could be explained solely by the A 9-THC content of the samples.
Methods

Plant material
Samples A and B were apprehended by the Sao Paulo State Police; sample C originated from a plant cultivated at the premises of Escola Paulista de Medicina. We are grateful to Drs Orlando Rosante and Diniz Junqueira from the Sao Paulo Police for supplying samples A and B and to Measure of corneal areflexia in rabbits (Gayer test). This was performed as described by Santos, Sampaio, Fernandes & Carlini (1966) .
Adult male albino rabbits weighing 2.5 to 3.5 kg were used. Suspensions of cannabis resins containing 0.5 to 4.0 mg/ml were injected at a constant speed of 0.04 ml/min through the marginal vein of the ear of adult albino rabbits. The corneal reflex was tested 10 times on each eye every 3 minutes. The abolition of at least 80% of the responses in the last three sets of tests was considered a positive assay, after which the infusion was discontinued. The total amount of cannabis resin injected was then calculated per kg of rabbit weight.
Measure of spontaneous motor activity in mice. Four photocell cages as described by Carlini & Silva (1968) were used. Male albino mice three months old and weighing 25-30 g were employed. Three or four doses in geometric progression were used for each drug, and at least 10 mice used for each dose. All drugs were given through the intraperitoneal route between 9 h 00 min and 10 h 00 min, and immediately after injections the animals were put into the cages where they remained for a period of 2 hours. The total number of light beam interruptions was counted and the values found for the control animals were taken as 100% for calculations of ED50 according to the log-probit-method of Miller (Karniol & Carlini, 1973 ).
Administration of the marihuana smoke to human subjects. A quantity (62.5 to 500 mg) of finely chopped plant, either A, B or C, was burned in a pipe connected through latex tubing to a 6 litre Palmer spirometer. The smoke inside the apparatus was then mixed with air to make 6 litres. Immediately after this operation (which took 2 to 3.5 min depending on the amount burned), the subjects started to inhale the mixture by mouth, with their noses blocked, according to the following schedule: 5 s of inhalation, 15 s of breath holding, 35 s of normal breathing of room air, until all 6 litres were consumed. This took six to nine cycles as described above or 5.5 to 8.5 minutes. To administer A9-THC, 0.1 to 0.4 ml of an alcoholic solution containing 50 mg/ml of A9 -THC was added to 500 mg of placebo powder and the mixture was thoroughly mixed to allow most of the alcohol to evaporate.
Test procedure. Table 2 summarizes the procedure. Each volunteer was physically examined, and interviewed by a psychiatrist (I.G.K.) to ensure that he had no history of severe psychopathology and that he was in apparent good mental health at the time of the experiment. They were then told in detail what was to be done, how they should inhale the smoke and that they would be asked to describe their feelings. The subjects were then asked to be seated in an isolated laboratory, and to relax while pulse rate was measured 10 times at 1 min intervals. After this the subjects performed a time production task, i.e. they were asked to estimate a 60 s interval, 10 times. In the first five estimations (Estimation T 1) there was no feedback from the experimenter. The following five estimations (Estimation T2) were performed with feedback, the experimenter saying either 'correct', 'too short', or 'too long' immediately after each estimation. The marihuana Grade 4: feelings of well-being followed later by panic; intense sensation of being watched; coherent thoughts impossible due to the rapid flow of ideas; in general, subject knows what is happening, but loses the knowledge from time to time and panic starts; cinaesthesia; striking visual hallucinations.
As explained above, in another series of parallel experiments several doses of A9-THC were given to rats, mice, rabbits and to human volunteers. The overall data and some aspects of the results will be given here; the details of the experimental procedure and other data are given elsewhere (Karniol & Carlini, 1973) .
Results
Human studies
General physical reactions of the subjects. Thirty-one of the subjects receiving marihuanas A, B or C did not present any marked physical signs or symptoms after the inhalation of smoke. Occasionally, paroxysmal episodes of coughing or a sensation of nausea were reported. However, two of the subjects who smoked 125 mg of marihuana B and 500 mg of marihuana A respectively, complained of faintness, vague physical discomfort and profuse sweating. The blood pressure of one of these subjects fell to 60/30 mmHg from a pre-drug level of 100/80 mnmHg. These symptoms were quickly relieved in both subjects by putting down their heads below body level. Such effects did not appear in the volunteers receiving A9 -THC.
Pulse rate. The larger doses of A9-THC and of marihuanas A and B increased pulse rate. The effect was seen even at the first measurement after the end of inhalation and reached a peak after a maximum of 8 min, returning to levels near normal within 20 to 50 minutes. The increase was dose-dependent. Table 3 shows the average results expressed as a percentage of the pre-smoking period. Plants A and B significantly increased pulse rate when compared to placebo and B was nearly twice as active as plant A; plant C had practically no effect. Marihuanas A and B induced effects of greater magnitude than were expected from their A9 -THC content. Thus, 500 mg of A (containing 4.0 mg of A9-THC) and 250 mg of B (5.0 mg of A9 -THC) induced an increase of pulse rate comparable to that obtained with 10 mg and larger than that seen with 5.0 mg of A9-THC.
Time production task. A9-THC, and marihuanas A and B affected estimation T3 significantly (Table 4 ). Sample C did not differ from placebo. Again, plant B was more active than plant A. The figures in Table 4 represent absolute deviations from 1 min (above or below). The direction of such deviations can be seen in Fig. 1 , for the largest doses of the three marihuana samples. After marihuanas A and B, respectively, 41 and 67% of the subjects estimated less than 55 s as being 1 minute. As no dose-effect relationships were obtained in this measure, direct comparison with A9-THC is difficult. Nevertheless, the effects of 250 and 500 mg of plant A (containing 2.0 and 4.0 mg of &9-THC) and of 125 and 250 mg of plant B (2.5 and 5.0 mg of A9-THC) were similar to those of 5 and 10 mg of A9-THC. Although objectively the subjects overestimated the length of time that had elapsed, they later said they had the impression that time was passing slowly and thought they had underestimated the passing of 60 seconds. However, these effects decreased when estimation was helped by feedback (estimation T4). with the greatest value after smoking. Student's t test, comparison made with placebo group: *PO 0.02; **P < 0.01; ***P < 0.005. § A small volume (0.1-0.4 ml) of an alcoholic solution containing 50 mg/ml A9-THC was added to 500 mg placebo powder and the mixture was thoroughly mixed to allow most of the alcohol to evaporate (see Karniol & Carlini, 1973) . (Same for Tables 4 and 5 .) Corneal areflexia in rabbits. Table 6 shows the results of these tests. Resin B was significantly more active than resins A and C but did not differ significantly from A9-THC. The actual net content of A9-THC in the injected amounts of resins, as Table 5 Distribution of subjects in a scale of psychological reactions, according to the effects produced by samples of marihuana and by A9-tetrahydrocannabinol (A9-THC). The asterisks indicate significant differences from controls (Student's t test; P < 0.05).
calculated from the chemical data of Table 1, are shown in the last column of Spontaneous motor activity in mice. Table 7 shows the decrease in motor activity produced by 10-80 mg/kg of A9-THC, resins A, B and C, and the ED50'S calculated from these data. The estimated ED50 for resin A (82.5 mg/kg) was extrapolated from the curve, as it was outside the experimental dose range. The same occasional need to extrapolate in order to obtain estimates of ED50's is also seen in Tables 8 and 9 . Resin B was more active than A and C in reducing the motor activity of mice. On the other hand, the resins were less active than A9-THC. However, as seen in the last column of Table 7 , resins A and B were more active than would be expected from their A9 -THC contents.
Catatonia activity in mice. The dose-response curves for A9-THC and sample B were apparently not parallel, which made a potency comparison difficult (Table 8) . However, a new experiment carried out with A9 -THC gave an ED50 of 37.1 ± 12.0 mg/kg. Furthermore, this lack of parallelism may be insignificant compared to the large limits of error found in the catatonia test. Thus, it seems that resin B, in this test, was also more active than resins A and C. As seen in Table 8 , their respective ED53's were 33.9, 52.5 and 89.3 mg/kg. On the other hand, sample B was as active as A9 -THC. However, the actual contents of A9-THC in the resins were smaller than expected, as can be seen in the last column of Table 8 .
Rope climbing performance of rats. Figure 2 and Table 9 summarize the results. Again, resin B was the most active and C the least active. No difference was found between resin B and A9-THC. Again, as shown in the last column of Table 9 , the A9-THC contents of the resins were smaller than expected.
Discussion
A9 -THC and two of three samples of marihuana smoked by volunteers under a standardized procedure, increased pulse rate, disrupted a time production task and induced psychological reactions which varied from mild to marked distortions in mood and perception. These effects, although they did not occur concomitantly, varied quantitatively according to the plant sample used. As a rule, the dose and/or the sample that was more active in changing pulse rate was also more efficient in disrupting the time production task and in inducing psychological symptoms. The peak pulse rate changes preceded peak psychological symptoms by 10 to 20 minutes. This symptomatology has been described before for marihuana and A9-THC (Weil et al., 1968; Manno et al., 1970; Manno et al., 1971; Isbell & Jasinski, 1969; Hollister, 1970; Isbell, Gorodetzsky, Jasinski, Claussen & Korte, 1967) . The effects on the time production task deserve further comment. The disruption was clearly observed at estimation T3, but decreased at estimation T4 when subjects were given feedback. This could be explained on the supposition that when the drugged subjects were left undisturbed, without feedback, the drug effects could manifest themselves more freely; and, as a consequence, the rapid flow of ideas could more readily impair concentration. Another interpretation could be that the drug's effect on the time task wears off very rapidly so that at estimation T4 the subjects were again able to estimate correctly. However, we favour the former hypothesis. It might be possible that the experimenter can limit the psychological effects of marihuana, and, when drugged subjects are given batteries of tests and other procedures, the total manifestations of a marihuana 'high' may not be seen. In this respect, it is interesting that Tinklenberg et al. (1970) reported that when the subjects were exhorted to try as hard as possible they could mitigate considerably the influence of marihuana on attention.
Comparison of potencies was made between A9 -THC and the marihuana samples, or among the samples, in spite of the large limits of error found in some experiments (for example, see Tables 8  and 9 ). However, as these limits of error are usually found in experiments with cannabis and as in all the experiments performed with rabbits, mice, rats and man, the same relative potencies were obtained, the differences found were taken into consideration.
Thus, the activity of marihuana B was approximately double that of A when pulse rate, time production task or psychological reactions were measured. Marihuana C, on the other hand, was practically inactive. The results obtained from rabbits, mice and rats paralleled those obtained in man, showing that marihuana B was twice as active as marihuana A, and that C possessed weak activity. This is evidence that marihuana has consistent effects depending upon potency amongst these four species and suggests that it is possible through animal tests to predict the potency of a marihuana sample in man. Thus, 250 to 500 mg of a plant, the petroleum ether extract of which abolishes the corneal reflex of rabbits at approximately 0.150 mg/kg, prolongs rope climbing time of rats at an ED50 of about 13 mg/kg, reduces motor activity and induces catatonia in mice at ED50's of 37 and 33 mg/kg respectively, can be expected under the conditions we have stated to induce strong psychological reactions in human subjects.
According to the chemical analysis (Table 1) , 250 mg of sample B and 500 mg of samples A and C should contain respectively 5.0, 4.0 and 2.5 mg of A9-THC. However, the results we have obtained with the human volunteers indicate that the activity of 250 mg of sample B and 500 mg of sample A was comparable to the effects of at least 10 mg of A9 -THC. The same discrepancy was also obtained with the laboratory animals; thus, as mentioned before in the Results, according to the Gayer test, 4.8 and 9.3% respectively of A9 -THC would be expected in samples A and B. Results greater than expected were also obtained in rats and mice.
These data suggest that the potency of the marihuana samples we have used cannot be explained solely on the basis of their content of A9 -THC. They can not be explained either by the amount of A8 -THC in samples A and B which was 0. 1%. ( We are grateful to National Institute of Mental Health for performing these assays.) It is possible, however, that a synergistic action of other compounds with A9-THC occurred. For example, Kubena & Barry (1972) sug;ested such a role for the n-propyl analogue of A -THC. It is interesting in this respect that not only the n-propyl but also a methyl analogue of A -THC has been identified in our sample B (Vree, Breimer, Van Ginneken & Van Rossum, 1972) . On the other hand, as we have suggested before (Karniol & Carlini, 1972) , the relatively large amount of cannabinol (Table 1) It is also pertinent that interaction between A9 -THC and other cannabis constituents may not be limited to potentiation. For example, cannabidiol has recently been found to inhibit some effects of A9 -THC in laboratory animals (Karniol & Carlini, 1973b 
